Key result
SARS-CoV and SARS-CoV-2 N proteins form fewer cytoplasmic condensates and antagonize stress granules versus other coronaviruses.
Why the study?
The reasons for differences in disease severity among human coronaviruses may be related to the properties of individual viral proteins, including the nucleocapsid protein's capacity to form condensates.
SARS-CoV and SARS-CoV-2 N proteins uniquely antagonize stress granule assembly, which may contribute to their higher pathogenicity compared to other human coronaviruses.
Answers are grounded in this paper and cite their sources.
May underlie SARS-CoV-2 pathogenicity via stress granule evasion; hypothesis-generating for antiviral targets pending human validation.
To date, seven human coronaviruses (HCoVs) have been identified. Four of these viruses typically manifest as a mild respiratory disease, whereas the remaining three can cause severe conditions that often result in death. The reasons for these differences remain poorly understood, but may be related to the properties of individual viral proteins. The nucleocapsid (N) protein plays a crucial role in the packaging of viral genomic RNA and the modification of host cells during infection, in part due to its capacity to form dynamic biological condensates via liquid-liquid phase separation (LLPS). In this study, we investigated the capacity of N proteins derived from all HCoVs to form condensates when transiently expressed in cultured human cells. A fraction of the transfected cells were observed to contain cytoplasmic granules in which the most of the N proteins were accumulated. Notably, the N proteins of SARS-CoV and SARS-CoV-2 showed a significantly reduced tendency to form cytoplasmic condensates. The condensate formation was not a consequence of overexpression of N proteins, as is typical for LLPS-inducing proteins. These condensates contained components of stress granules (SGs), indicating that the expression of N proteins caused the formation of SGs, which integrate N proteins. Thus, the N proteins of two closely related viruses, SARS-CoV and SARS-CoV-2, have the capacity to antagonize SG induction and/or assembly, in contrast to all other known HCoVs.
No takes yet. Share an insight, caveat, or question.
Tikhomirova et al. (2024) studied Human coronavirus. N proteins of SARS-CoV and SARS-CoV-2 vs. N proteins of other human coronaviruses was evaluated on Capacity to form cytoplasmic condensates. The N proteins of SARS-CoV and SARS-CoV-2 showed a significantly reduced tendency to form cytoplasmic condensates and antagonized stress granule induction compared to other human coronaviruses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: